Director-Affiliated Fund Sells $45.5M in Aurora Innovation Shares
AUR sits 93% above its 52-week low of $3.6.
Summary
A fund affiliated with Director Reid Hoffman sold $45.5 million worth of Aurora Innovation Class A Common Stock over several days in May.
Key Events · Ownership and Investor Activity · AUR
-
Director-Affiliated Fund Sales
Entities associated with Director Reid Hoffman sold 5,846,133 shares of Class A Common Stock for a total of $45,542,439.
-
Transaction Dates and Prices
Sales occurred between May 15 and May 18, 2026, at weighted average prices ranging from $7.51 to $7.81 per share.
-
Conversion Activity Preceding Sales
Prior to the sales, there were conversions of Class B Common Stock to Class A Common Stock on October 31, 2025, totaling 7,048,487 shares. These conversions are typically a precursor to open market sales.
-
Significant Reduction in Holdings
The reporting person's indirect holdings through various affiliated entities have significantly decreased following these transactions.
Analysis · AUR · Technology
This Form 4 reports significant sales by entities associated with Director Reid Hoffman, totaling over $45.5 million. While these are sales from affiliated funds rather than direct personal sales, the substantial value represents a notable reduction in exposure by a key insider's associated entities. This follows recent Form 144 filings indicating intent to sell by a director-affiliated fund, confirming the execution of a large portion of those planned sales.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.8% of the 1190 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AUR was trading at $6.94 on NASDAQ in the Technology sector, with a market capitalization of approximately $13.6B. The 52-week trading range was $3.60 to $8.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.